Assessing the quality of health care in the management of bronchiolitis in Australian children: a population-based sample survey.
clinical practice guidelines
compliance
quality measurement
Journal
BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
30
10
2018
revised:
12
03
2019
accepted:
18
03
2019
pubmed:
4
4
2019
medline:
22
5
2020
entrez:
4
4
2019
Statut:
ppublish
Résumé
Bronchiolitis is the most common cause of respiratory hospitalisation in children aged <2 years. Clinical practice guidelines (CPGs) suggest only supportive management of bronchiolitis. However, the availability of CPGs do not guarantee that they are used appropriately and marked variation in the clinical management exists. We conducted an assessment of guideline adherence in the management of bronchiolitis in children at a subnationally representative level including inpatient and ambulatory services in Australia. We searched for national and international CPGs relating to management of bronchiolitis in children and identified 16 recommendations which were formatted into 40 medical record audit indicator questions. A retrospective medical record review assessing compliance with the CPGs was conducted across three types of healthcare setting: hospital inpatient admissions, emergency department (ED) presentations and general practice (GP) consultations in three Australian states for children aged <2 years receiving care in 2012 and 2013. Purpose-trained surveyors conducted 13 979 eligible indicator assessments across 796 visits for bronchiolitis at 119 sites. Guideline adherence for management of bronchiolitis was 77.3% (95% CI 72.6 to 81.5) for children attending EDs, 81.6% (95% CI 78.0 to 84.9) for inpatients and 52.3% (95% CI 44.8 to 59.7) for children attending GP consultations. While adherence to some individual indicators was high, overall adherence to documentation of 10 indicators relating to history taking and examination was poorest and estimated at 2.7% (95% CI 1.5 to 4.4). The study is the first to assess guideline-adherence in both hospital (ED and inpatient) and GP settings. Our study demonstrated that while the quality of care for bronchiolitis was generally adherent to CPG indicators, specific aspects of management were deficient, especially documentation of history taking.
Sections du résumé
BACKGROUND
Bronchiolitis is the most common cause of respiratory hospitalisation in children aged <2 years. Clinical practice guidelines (CPGs) suggest only supportive management of bronchiolitis. However, the availability of CPGs do not guarantee that they are used appropriately and marked variation in the clinical management exists. We conducted an assessment of guideline adherence in the management of bronchiolitis in children at a subnationally representative level including inpatient and ambulatory services in Australia.
METHODS
We searched for national and international CPGs relating to management of bronchiolitis in children and identified 16 recommendations which were formatted into 40 medical record audit indicator questions. A retrospective medical record review assessing compliance with the CPGs was conducted across three types of healthcare setting: hospital inpatient admissions, emergency department (ED) presentations and general practice (GP) consultations in three Australian states for children aged <2 years receiving care in 2012 and 2013.
RESULTS
Purpose-trained surveyors conducted 13 979 eligible indicator assessments across 796 visits for bronchiolitis at 119 sites. Guideline adherence for management of bronchiolitis was 77.3% (95% CI 72.6 to 81.5) for children attending EDs, 81.6% (95% CI 78.0 to 84.9) for inpatients and 52.3% (95% CI 44.8 to 59.7) for children attending GP consultations. While adherence to some individual indicators was high, overall adherence to documentation of 10 indicators relating to history taking and examination was poorest and estimated at 2.7% (95% CI 1.5 to 4.4).
CONCLUSIONS
The study is the first to assess guideline-adherence in both hospital (ED and inpatient) and GP settings. Our study demonstrated that while the quality of care for bronchiolitis was generally adherent to CPG indicators, specific aspects of management were deficient, especially documentation of history taking.
Identifiants
pubmed: 30940731
pii: bmjqs-2018-009028
doi: 10.1136/bmjqs-2018-009028
pmc: PMC6837255
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
817-825Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Pediatrics. 2011 Dec;128(6):1053-61
pubmed: 22065263
BMJ Open. 2015 Apr 08;5(4):e007749
pubmed: 25854977
Basic Clin Pharmacol Toxicol. 2015 Apr;116(4):337-42
pubmed: 25168517
BMJ Open. 2015 Apr 08;5(4):e007748
pubmed: 25854976
JAMA. 1999 Oct 20;282(15):1440-6
pubmed: 10535434
Cochrane Database Syst Rev. 2014 Jun 17;(6):CD001266
pubmed: 24937099
CMAJ. 2003 Nov 11;169(10):1023-8
pubmed: 14609971
Pediatrics. 2008 Dec;122(6):1196-203
pubmed: 19047234
Eur J Pediatr. 2012 Jul;171(7):1109-19
pubmed: 22350372
J Pediatr. 1996 Sep;129(3):390-5
pubmed: 8804328
Clin Pediatr (Phila). 1999 Jul;38(7):395-9
pubmed: 10416095
Pediatrics. 2006 Jul;118(1):114-23
pubmed: 16818556
J Antimicrob Chemother. 2004 Dec;54(6):1116-21
pubmed: 15546973
Pediatrics. 2018 Jun;141(6):
pubmed: 29752289
J Pediatr. 2012 Dec;161(6):1104-8
pubmed: 22748516
Pediatrics. 2001 Oct;108(4):851-5
pubmed: 11581435
Evid Rep Technol Assess (Summ). 2003 Jan;(69):1-5
pubmed: 12624885
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001279
pubmed: 16034861
Pediatrics. 2014 Mar;133(3):e730-7
pubmed: 24534398
Health Inf Manag. 2009;38(1):35-46
pubmed: 19293434
Pediatrics. 2008 Dec;122(6):1165-70
pubmed: 19047229
BMJ. 2011 Apr 06;342:d1658
pubmed: 21471173
BMC Fam Pract. 2008 Jan 31;9:10
pubmed: 18237423
Med J Aust. 2012 Jul 16;197(2):100-5
pubmed: 22794056
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Arch Pediatr Adolesc Med. 1998 Aug;152(8):739-44
pubmed: 9701131
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD003123
pubmed: 21678340
J Pediatr (Rio J). 2017 Nov - Dec;93 Suppl 1:75-83
pubmed: 28859915
Paediatr Child Health. 1999 Apr;4(3):195-9
pubmed: 20212965
Pediatrics. 2005 Apr;115(4):878-84
pubmed: 15805359
N Engl J Med. 2003 Jun 26;348(26):2635-45
pubmed: 12826639
J Antimicrob Chemother. 2014 Dec;69(12):3423-30
pubmed: 25091508
BMC Pediatr. 2007 Jan 24;7:4
pubmed: 17250764
JAMA. 2018 Mar 20;319(11):1113-1124
pubmed: 29558552
Acad Emerg Med. 2004 Apr;11(4):353-60
pubmed: 15064208